Table 6.
Characteristic | OR | 95% CI | p Value | |
---|---|---|---|---|
Age (years) | ||||
<55 | REF | |||
55–64 | 0.89 | 0.55 | 1.45 | 0.65 |
65–74 | 1.23 | 0.75 | 1.99 | 0.41 |
75–84 | 1.60 | 0.94 | 2.73 | 0.08 |
85+ | 2.13 | 0.84 | 5.39 | 0.11 |
Sex | ||||
Male | REF | |||
Female | 1.25 | 0.89 | 1.74 | 0.19 |
Deprivation | ||||
1 least deprived | REF | |||
2 | 1.06 | 0.67 | 1.69 | 0.80 |
3 | 1.21 | 0.75 | 1.95 | 0.43 |
4 | 1.64 | 0.97 | 2.76 | 0.07 |
5 most deprived | 1.19 | 0.65 | 2.21 | 0.57 |
Physical activity* | 0.91 | 0.84 | 0.98 | 0.01 |
Number of other LTC (excluding BP) | ||||
0 | REF | |||
1 | 2.16 | 1.44 | 3.24 | <0.001 |
2+ | 7.26 | 4.51 | 11.69 | <0.001 |
Treatment† | ||||
Chemo only | REF | |||
Radio+chemo | 0.81 | 0.47 | 1.41 | 0.46 |
Chemo+antibody | 0.93 | 0.55 | 1.59 | 0.80 |
Radio+chemo+other | 1.55 | 0.87 | 2.77 | 0.14 |
Other | 0.96 | 0.63 | 1.46 | 0.86 |
Ethnicity | ||||
White | REF | |||
Mixed | 2.78 | 0.28 | 27.7 | 0.38 |
Asian | 0.68 | 0.29 | 1.59 | 0.38 |
Black | 0.91 | 0.33 | 2.49 | 0.85 |
Other | 0.61 | 0.09 | 4.39 | 0.62 |
Disease status | ||||
Remission | REF | |||
Rx but present | 2.57 | 1.52 | 4.33 | <0.001 |
Not treated | 0.83 | 0.17 | 3.96 | 0.82 |
Recurrence | 3.73 | 1.68 | 8.29 | 0.001 |
Not sure | 3.04 | 1.58 | 5.84 | 0.001 |
Time since diagnosis (years) | ||||
1 | REF | |||
2 | 0.62 | 0.38 | 0.99 | 0.05 |
3 | 0.60 | 0.38 | 0.96 | 0.03 |
5 | 0.57 | 0.36 | 0.90 | 0.02 |
*Amount of physical activity performed each week quantified according to the Chief Medical Officer of England's recommendations.16
†Odds of reporting ‘medium’ or ‘low’ QoL EQ5D scores compared with ‘high’ QoL scores where ‘high’, ‘medium’ and ‘low’ QoL was defined as scores=1, 0.5≤scores<1 and scores<0.5, respectively.
LTC,long-term condition; QoL, quality of life.